Stay updated on Sabatolimab in HMA for Higher Risk MDS Clinical Trial
Sign up to get notified when there's something new on the Sabatolimab in HMA for Higher Risk MDS Clinical Trial page.

Latest updates to the Sabatolimab in HMA for Higher Risk MDS Clinical Trial page
- Check4 days agoChange DetectedThe page's Revision tag was updated from v3.6.6 to v3.7.0, reflecting a new version of the Study Record History page. This indicates an under-the-hood update to the page template rather than a change to the study information.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedRevision metadata in the history has been updated from v3.6.5 to v3.6.6, signaling a minor version bump in the site's revision tracking.SummaryDifference0.1%

- Check46 days agoChange DetectedThe history now includes a new revision entry v3.6.5 and removes the previous revision v3.6.4, reflecting an update to the page's version tracking.SummaryDifference0.1%

- Check60 days agoChange DetectedThe record history shows a new software revision, v3.6.4, replacing the previous v3.6.3. This reflects a back-end or UI update to the page history display and does not alter study data or status.SummaryDifference0.1%

- Check82 days agoChange DetectedNew revision entry v3.6.3 was added to the history. The previous revision v3.6.2 was removed, updating the documented version trail for the study record.SummaryDifference0.1%

- Check89 days agoChange DetectedThe study record history now includes revision v3.6.2, replacing the prior revision v3.6.0. This reflects an administrative update to the page's versioning rather than a change to trial data or conduct.SummaryDifference0.1%

Stay in the know with updates to Sabatolimab in HMA for Higher Risk MDS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sabatolimab in HMA for Higher Risk MDS Clinical Trial page.